Fogerite S.; Targeting immune response induction with cochleate and liposome-based vaccines; Adv Drug Deliv Rev Jul 6;32(3):

Size: px
Start display at page:

Download "Fogerite S.; Targeting immune response induction with cochleate and liposome-based vaccines; Adv Drug Deliv Rev Jul 6;32(3):"

Transcription

1 1. Kheiri, M.T., Edghill-Smith, Y., Das, K., Wang, Z., Feketeova, E., Mannino, R.J., and Gould-Fogerite, S., The use of cochleate-based subunit influenza vaccines to elucidate the regulation of mucosal and circulating immune responses and generation of protective immunity in mice. Abstract in first Annual International Conferece on Novel Vaccine Strategies; Mucosal Immunization, Adjuvants and genetic approaches; Oct. 6-8, 1993, Bethesda, MD., USA. 2. Gould-Fogerite S, Edghill-Smith Y, Kheiri M, Wang Z, Das K, Feketeova E, Canki M, Mannino RJ.; Lipid matrix-based subunit vaccines: a structure-function approach to oral and parenteral immunization; AIDS Res Hum Retroviruses. 1994; 10 Suppl 2:S Review. 3. Gould-Fogerite S, Zhang F, Kheiri M, Edghill-Smith Y, Wang Z, Brois D, Chen ZW, Scolpino A, Lu R, Mautone A, Feketeova E, Mannino RJ. Conf Adv AIDS Vaccine Dev 1997 Conf Adv AIDS Vaccine Dev 1997 Bethesda Md May 4-7; Mannino RJ, Canki M, Feketeova E, Scolpino AJ, Wang Z, Zhang F, Kheiri MT, Gould- Fogerite S.; Targeting immune response induction with cochleate and liposome-based vaccines; Adv Drug Deliv Rev Jul 6;32(3): Mohaghegh Hazrati,S., Ph.D, Ali-Nedjad, M. M.Sc, Kheiri, M. Ph.D et.al. 2000; The role of GW-1, GM-1, PPD-A and PPD-B as immunopotent adjuvants in cell Mediated Immune responses against recombinant gp63 in BALB/c. Abstract in The first National Congress of Biotechnology, Tehran, Iran, Feb Kheiri, M.T., et. al., Protective immunity in mice following immunization with the cochleate-based subunit influenza vaccines. Iranian Biomedical Journal 2001; 5(1): Gould-Fogerite, S., Kheiri, M., Zhang, F., and Mannino, R.J. Cochleate Delivery Vehicles: Applications in Vaccine Delivery. J Liposome Research, 10: , Kheiri, M.T., Aligejad, M., et al., 2001, Immunological analysis of recombinant gp63 and truncated forms of Leishmania major with new adjuvants, Abstract in Worldleish II Congress, May 2001, Crete-Greece. 9. Montazeri, M, MSc, Kheiri, M.T., Ph.D., et. al. 2001, Cloning and expression of the L.Major gp63 gene in prc/rsv as DNA vaccine. Abstract in The 6th Congress of what's New in Dermatology, 9-11 May 2001, Isfahan, Iran.

2 10. Karimi, M; Salehzadeh, F; Zeinodini, M; Akbari, B.; Kheiri, M.T. ; Maghsoudi, N.; 2001, Detection of CVB3 infection in Biological Specimens using Multiplexp-RT PCR. Abstract submitted to 1st. Iranian Congress of Virology, Tehran, Iran. 11. Karimi, M., Salehzadeh, F, zeinoddini, M., Akbari, B., Tavassoti Kheiri, M., Maghsoudi, N. ; Detection of CVB3 infection in biologic specimens by multiplex- RT PCR Ibid proceeding book p Salehzadeh, F; Karimi, M; Zeinodini, M; Akbari, B.; Kheiri, M.T. ; Maghsoudi, N.; 2001, Detection of CVB3 RNA in Biological Specimens using In situ Hybridization Method (ISH). Abstract submitted to 1st. Iranian Congress of Virology, Tehran, Iran. 13. Salehzadeh, F., Karimi, M., Zeinoddini, M., Akbari, B., Tavassoti Kheiri, M., Maghsoudi; Detection of Coxsaekievirus RNA (CVB3) in biological Specimen by ISH method. Ibid proceeding book: p The experimental production of inactivated influenza whole virus vaccine; Esmaeil Saberfar, M. Tavassoti Kheiri, H.Mohammadi, M.Tabatabaeian, R.Bashar, M.Ahmadi Bidhendi; Abstract submitted to the 1 st Iranian Congress of Virology; 2002,Tehran, Iran. 15. Immunological responses of BALB/c mice against rgp63 protein and DNA formualted in bacterial ghost; Masoumeh T. Kheiri, Werner Leubitz, Susanne Pahrkner, Mehrnaz Amani, Rouzbeh Bashar, Mansoureh Tabatabaeian, Rasoul Soleimani, Fereidoun Mahboudi; Abstract submitted to NAMBB 2003, Vienna Austria. 16. Influenza A Virus Propagation in Cell Culture; Simin Abbasi, Manijeh Ahmadi Bidhendi, Mansoureh Tabatabaeian, Rouzbeh Bashar, Masoumeh Tavassoti Kheiri; Abstract submitted to the 2 nd Iranian Congress of Virology, 2004, Tehran, Iran. 17. HBV Contamination of Dental Instruments in Operative Department of Dentistry School of Tehran University on 1382; Rouzbeh Bashar, Mansoureh Tabatabaeian, Hamid Aghaie, Samad Amini Bavil Oliaie, Azadeh Barforoushan, Sakineh Arami, Masoumeh Tavassoti Kheiri; Abstract submitted to the 2 nd Iranian Congress of Virology, 2004, Tehran, Iran. 18. DNA Immunization of BALB/c Mouse with Bacterial Ghosts Containing DNA-Plasmid Encoding GP63 of Leishmania Major and Defining Type of Immune Responses; R. Soleymani, P. Pakzad, F. Mahbudi, R. Bashar, M. tabatabaian, F. Barkhordari, M. T. kheiri. Abstract submitted to the 7 th Congress of Immunology and Allergy, 2004, Mashhad, Iran.

3 19. The Study of TH 1 and TH 2 Cytokine Profile (IFN γ, IL-12, IL-4, IL-10) in PBMCs of Patients with MDR-TB and Newly Diagnosed Treated Cases Tuberculosis. N. Miandehi, M. Shekarabi, D. Mansoori, M.T.Kheiri, M. Mirsaeedi. Abstract submitted to the 7 th Congress of Immunology and Allergy, 2004, Mashhad, Iran. 20. HBV DNA removal from dental instruments following disinfection with 2:100 dilution of 5% Sodium Hypochlorite; Leila Mahrokh, Mansoureh Tabatabaian, Rouzbeh Bashar, Rasoul Soleimani Astyar, Shora Foroutan, Sakineh Arami, M asoumeh T. Kheiri; Abstract presented on 3 rd Iranian Congress of Virology, Jan. 2006, Tehran-Iran. 21. Mansoureh Tabatabaeian; Leila Mahrokh; Rouzbeh Bashar; Rasoul Soleymani; Mohamad Ali Nadeali, Sakineh Arami, Masoumeh Tavassoti Kheiri; Jan. 2006; Qualification of 3 Disinfectants on HBV DNA Removal from Dental Instruments; Abstract presented on 3 rd Iranian Congress of Virology, Tehran-Iran. 22. Mahsa Shahidi, Mansoureh Tabatabaian, Rouzbeh Bashar, Samad Amini-Bavil-Olyaee, Ramin Sarami Foroushani, Fereidoun Mahboudi, Masoumeh Tavassoti Kheiri; 2006; Influenza Virus Typing and Subtyping by Multiplex RT-PCR; Abstract presented on 3 rd Iranian Congress of Virology, Jan. 2006, Tehran-Iran. 23. Arami S., Tavassoti Kheiri M., Bashar R., Nadali MA; Evaluation of the effect of three disinfectants on removing HBV contamination (in Farsi); Journal of Dentistry, University of Medical Sciences, Health Services and Teatment of Tehran Spring 2006 Vol. 19 No Jaafari MR, Ghafarian A, Farrokh-Gisour A, Samiei A, Kheiri MT, Mahboudi F, Barkhordari F, Khamesipour A, McMaster WR.; Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice; Vaccine Jul 17; 24(29-30): M. Tavassoti Kheiri, M. Shahidi, M. Tabatabaian, R. Bashar, S. Amini-Bavil-Olyaee, R. Soleimani Astiar, M. Hosseini, F. Mahboudi; 2006; The First Molecular and Phylogenetic Analysis of Influenza Virus Isolated from Iranian Patients in Shiraz-Iran; Accepted for poster presentation in 12 th International Congress on Infectious Diseases, June 2006, Lisbon-Portugal; The poster was presented in Annual Scientific Meeting of Pasteur Institutes held Oct. 2006, Hanoi, Vietnam. 26. Shahidi M, Kheiri MT, Amini-Bavil-Olyaee S, Hosseini M, Moattari A, Tabatabaeian M, Bashar R, Sarrami-Forooshani R, Mahboudi F.; Molecular and phylogenetic analysis of

4 human influenza virus among Iranian patients in Shiraz, Iran; J of Med Virol Apr 24; 79(6): Mahsa Shahidi, Masoud Hosseini, Fereidoun Mahboudi, Samad Amini-Bavil-Olyaee, Afagh Moattari, Mansoureh Tabatabaian, Rouzbeh Bashar, Masoumeh Tavassoti Kheiri; Molecular and phylogenetic analysis of human influenza virus among Iranian patients in Shiraz, Iran; Abstract presented on 4 th Iranian Congress of Virology, May. 2007, Tehran- Iran. 28. Y. Panahi, R. Saghiri, R. Soleimani Estyar, B. Farahmand, R. Bashar, M. Tabatabaeian, P. Mehrbod, M. T. Kheiri; Extraction & analysis of NP protein extracted from Influenza Viruses; Abstract presented on 4 th Iranian Congress of Virology, May. 2007, Tehran-Iran. 29. P. Mehrbod, N. Motamed, M. Tabatabaian, R.Soleimani Estiar, E.Amini, Y. Panahi, M. T. Kheiri; Antiviral Effect Analysis of "Nanosilver" on Influenza Virus Cell Culture; Abstract presented on 4 th Iranian Congress of Virology, May. 2007, Tehran-Iran. 30. Fatemeh Rouhollah, Khader Khalilie, Masoumeh Tavassoti Kheiri, Fereidoun Mahboudi; Investigate immuno responses with recombinant fusion protein gp41-p24 (HIV1); Abstract presented on 4 th Iranian Congress of Virology, May. 2007, Tehran-Iran. 31. Z. Soltani, M. Hosseini,,M.Tabatabaian, R. Bashar, R. Soleimani Estiar, M. T. Kheiri; Isolation and molecular identification of influenza virus from patient samples in Tehran; Abstract presented on 4 th Iranian Congress of Virology, May. 2007, Tehran-Iran. 32. Jaafari MR, Badiee A, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F; The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome; Vaccine Aug 10;25(32): Ziba Soltani, Masoud Hosseini, Mansoureh Tabatabaian, Rouzbeh Bashar, Mahsa Shahidi, Masoumeh Tavassoti Kheiri; Detection of Human Influenza Viruses in Nasopharyngeal Samples by RT-PCR Vs Tissue Culture; Iranian Journal of Virology, (3): Karimi, Vahid, Ghalyanchi Langeroudi, Arash., Bozorgmehri Fard, Mohammad Hassan, Mahboudi, Fereidoun, Barin, Abbas, Tavassoti Kheiri, Masoumeh; Amino Acid Sequence Analysis of Hemagglutinin Protein of H9N2 Isolated From Broilers in Tehran in 2007; Iranian Journal of Virology, (3):

5 35. Soltani Z, Hosseini M, Shahidi M, Hedayati M, Kheiri MT; Molecular analysis of human influenza virus in Tehran, Iran; Intervirology. 2009; 52(2):63-7. Epub 2009 Apr Mehrbod P., Motamed N., Tabatabaian M., Soleimani Estyar R, Amini E., Shahidi M., Kheiri M.T; In Vitro Antiviral Effect of "Nanosilver" on Influenza Virus; 2009; DARU. Vol. 17, No Badiee A, Jaafari MR, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster W R, Mahboudi F. The role of liposome charged on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania( rgp63 ) 2009 Apr ;121(4):362-9.Epub 2009 Jan1. I 40. Jamali A, Sabahi F, Bamdad T, Hashemi H, Mahboudi F, Kheiri MT A DNA vaccine-encoded nucleoprotein of influenza virus fails to induce cellular immune responses in a diabetic mouse model. Clin Vaccine Immunol Apr;17(4): Epub 2010 Feb Farahman B (Ph.D), KhodanabdehM(Ph.D), Mahboudi F( Ph.D), Fotouhi F(Ph.D), Barkhordari F(BSc), Saleh M(Msc), Kheiri T M(Ph.D) Isolation,cloning, and sequencing of influenza A (H1N1) hemagglutinin for production of hemagglutinin gene bank production of hemagglutinin gene bank; Arak Medical University Journal(AMUJ)19 May 2010, Winter 2011;13(4): 59-67

Curriculum Vitae of Dr. Rouzbeh Bashar

Curriculum Vitae of Dr. Rouzbeh Bashar Curriculum Vitae of Dr. Rouzbeh Bashar Feb. 18th 2012 First name: Rouzbeh Second Name: Bashar Date of Birth: Sept. 28 th 1962 Place of Birth: Tehran Iran Nationality: Iranian Marital Status: Married Gender:

More information

CURRICULUM VITAE M.Sc. in Medical Virology, Tarbiat Modarres University, Tehran, Iran.

CURRICULUM VITAE M.Sc. in Medical Virology, Tarbiat Modarres University, Tehran, Iran. CURRICULUM VITAE Fatemeh Fotouhi Ph.D in Medical Virology Associate Proffessor Influenza and other Respiratory Viruses Pasteur Institute of Iran, Tehran, Iran. Phone #: +98 (21)64112183 Fax #: +98 (21)66496517

More information

In Vitro Antiviral Effect of "Nanosilver" on Influenza Virus

In Vitro Antiviral Effect of Nanosilver on Influenza Virus DARU Vol 17, No. 2 2009 88 In Vitro Antiviral Effect of "Nanosilver" on Influenza Virus 1 Mehrbod P., 1 Motamed N., 2 Tabatabaian M., 2 Soleimani Estyar R 2 Amini E., 2 Shahidi M., *2 Kheiri M.T 1 Tehran

More information

Nanosilver in the treatment of localized cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): an in vitro and in vivo study

Nanosilver in the treatment of localized cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): an in vitro and in vivo study DARU Vol. 17, No. 4 2009 285 Nanosilver in the treatment of localized cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): an in vitro and in vivo study *1 Mohebali M., 2 Rezayat M.M., 3

More information

Postdoctoral fellow in Queen s University, Department of M icrobiology and

Postdoctoral fellow in Queen s University, Department of M icrobiology and CURRICULUM VITAE Name: Fatemeh Fotouhi Date of birth: Jan. 13, 1966 Place of birth: Iran,Tehran Marital Status: Married, 2 children Address: Influenza unit, Department of Virology, Pasteur Institute of

More information

Parvaneh Mehrbod Date of birth: Previous Address: Current Address: Mobile number: Field of expertise: Education: PhD: M.Sc: B.

Parvaneh Mehrbod Date of birth: Previous Address: Current Address: Mobile number:   Field of expertise: Education: PhD: M.Sc: B. Parvaneh Mehrbod Date of birth: April 28, 1976 Previous Address:Laboratory of vaccine and immunotherapeutic, Institute of Bioscience, Universiti Putra Malaysia, UPM Serdang, 43400, Selangor, Malaysia Current

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle   holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/35908 holds various files of this Leiden University dissertation Author: Soema, Peter Title: Formulation of influenza T cell peptides : in search of a universal

More information

Hamid M. Niknam, Ph.D.

Hamid M. Niknam, Ph.D. Hamid M. Niknam, Ph.D. PERSONAL IDENTIFICATIONS: Name: Hamid Family name: Mahmoudzadeh Niknam Date of birth: 1959 Place of birth: Tehran Address: Department of Immunology, Pasteur Institute of Iran, No

More information

Cationic Liposome-DNA Complexes as Immunomodulators and Vaccine Adjuvants

Cationic Liposome-DNA Complexes as Immunomodulators and Vaccine Adjuvants Cationic Liposome-DNA Complexes as Immunomodulators and Vaccine Adjuvants September 29, 28 Platform Technology Proprietary Cationic Lipid-DNA Complexes Cationic/Neutral Lipid + DNA = JVRS-1 JVRS-1 + Antigen

More information

Efficacy of Four Disinfectants Against Hepatitis B Virus

Efficacy of Four Disinfectants Against Hepatitis B Virus Original Article Efficacy of Four Disinfectants Against Hepatitis B Virus Mohammadreza Aghasadeghi 1, Sakineh Arami 2, Masomeh Hasani Tabatabaie 3, Hojat Darvishpour 4, Mohammadjavad Kharazifard 5, Hamid

More information

Influenza 2009: Not Yet The Perfect Storm

Influenza 2009: Not Yet The Perfect Storm Influenza 2009: Not Yet The Perfect Storm What s needed for a pandemic strain? Novel virus (little to no immunity) Capable of causing disease in humans Highly pathogenic / virulent Capable of sustained

More information

1918 Influenza; Influenza A, H1N1. Basic agent information. Section I- Infectious Agent. Section II- Dissemination

1918 Influenza; Influenza A, H1N1. Basic agent information. Section I- Infectious Agent. Section II- Dissemination 1918 Influenza; Influenza A, H1N1 Basic agent information Section I- Infectious Agent Risk Group: - RG3 Synonym or Cross reference: - Spanish Flu - 1918 Flu - El Grippe Characteristics: - SELECT AGENT

More information

Panel about Brucellosis treatment in 7th midyear conference of infectious. Panel about Hepatitis in 6th midyear conference of infectious diseases.

Panel about Brucellosis treatment in 7th midyear conference of infectious. Panel about Hepatitis in 6th midyear conference of infectious diseases. Lectures/Seminars: Lectures: Panel about vaccination. 8 th midyear conference of infectious diseases. Babolsar, Iran (2009). Panel about Brucellosis treatment in 7th midyear conference of infectious diseases.

More information

Gene Vaccine Dr. Sina Soleimani

Gene Vaccine Dr. Sina Soleimani Gene Vaccine Dr. Sina Soleimani Human Viral Vaccines Quality Control Laboratory (HVVQC) Titles 1. A short Introduction of Vaccine History 2. First Lineage of Vaccines 3. Second Lineage of Vaccines 3. New

More information

A Multicistronic DNA Vaccine Induces Significant Protection against Tuberculosis in Mice and Offers Flexibility in the Expressed Antigen Repertoire.

A Multicistronic DNA Vaccine Induces Significant Protection against Tuberculosis in Mice and Offers Flexibility in the Expressed Antigen Repertoire. Company LOGO A Multicistronic DNA Vaccine Induces Significant Protection against Tuberculosis in Mice and Offers Flexibility in the Expressed Antigen Repertoire. Fayaz Ahmad Mir, Stefan H. E. Kaufmann,

More information

The humoral immune responses to IBV proteins.

The humoral immune responses to IBV proteins. The humoral immune responses to IBV proteins. E. Dan Heller and Rosa Meir The Hebrew University of Jerusalem, Israel COST FA1207 meeting WG2 + WG3, Budapest, Jan. 2015 1 IBV encodes four major structural

More information

Existence of reassortant A (H1N2) swine influenza viruses in Saitama Prefecture, Japan

Existence of reassortant A (H1N2) swine influenza viruses in Saitama Prefecture, Japan International Congress Series 1263 (2004) 749 753 Existence of reassortant A (H1N2) swine influenza viruses in Saitama Prefecture, Japan Shin ichi Shimada a, *, Takayasu Ohtsuka b, Masayuki Tanaka b, Munehito

More information

Nanoparticulate Vaccine Design: The VesiVax System

Nanoparticulate Vaccine Design: The VesiVax System Nanoparticulate Vaccine Design: The VesiVax System Gary Fujii, Ph.D. President and CEO Molecular Express, Inc. May 16, 2006 Orlando, Florida Influenza Each year up to 20% of the world's population contracts

More information

Topical effectiveness of different concentrations of nanosilver solution on Leishmania major lesions in Balb/c mice

Topical effectiveness of different concentrations of nanosilver solution on Leishmania major lesions in Balb/c mice J Vector Borne Dis 49, Dec 2012, pp. 249 253 Topical effectiveness of different concentrations of nanosilver solution on Leishmania major lesions in Balb/c mice Mohammad Ali Nilforoushzadeh 1, Leila Shirani-Bidabadi

More information

Complementary Course in Advance Methods of Molecular Biology , Bristol UK

Complementary Course in Advance Methods of Molecular Biology , Bristol UK Education: Complementary Course in Advance Methods of Molecular Biology. 2005-2006, Bristol UK PhD In Medical Immunology. Tarbiat Modarres University, 2006. Tehran, Iran. Diploma of The Institute of Homeopathy

More information

Original Article Development and Sequence Analysis of a Cold-Adapted Strain of Influenza A/New Caledonia/20/1999(H1N1) Virus

Original Article Development and Sequence Analysis of a Cold-Adapted Strain of Influenza A/New Caledonia/20/1999(H1N1) Virus Iranian Journal of Virology 2011;5(4): 6-10 2011, Iranian Society for Virology Original Article Development and Sequence Analysis of a Cold-Adapted Strain of Influenza A/New Caledonia/20/1999(H1N1) Virus

More information

HIV . HIV-1 HIV. . NJplot. Nested RT-PCR . CRF35-AD

HIV . HIV-1 HIV. . NJplot. Nested RT-PCR . CRF35-AD (-) HIV-1 POL HIV.. HIV-1 HIV Nested RT- HIV-1. PTZ-57RT PCR.. ClustalW /. NJplot Nested RT-PCR.. CRF35-AD. CRF35-AD. HIV1 : // : // : : PhD : - PhD - HIV-1 POL. HIV.. HIV-1 PCR CRFs= ) (Criculating Recombinant

More information

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON VIRUSES Biology Applications Control David R. Harper GS Garland Science Taylor & Francis Group NEW YORK AND LONDON vii Chapter 1 Virus Structure and 2.2 VIRUS MORPHOLOGY 26 Infection 1 2.3 VIRAL CLASSIFICATION

More information

B B (P 0/05) . High-risk. ( )..

B B (P 0/05) . High-risk. ( ).. : 3 2 1 B : B. B. : 76.. ELISA B. 86/8 6/6 6/6 : B. B (P 0/05) (100> B ).. High-risk. B : 1 firozzadfatah@gmail.com ( ).. 2.. 3.. ١ Postvaccination Hepatitis B Antibody titer on students of Ardebil College

More information

Acute respiratory illness This is a disease that typically affects the airways in the nose and throat (the upper respiratory tract).

Acute respiratory illness This is a disease that typically affects the airways in the nose and throat (the upper respiratory tract). Influenza glossary Adapted from the Centers for Disease Control and Prevention, US https://www.cdc.gov/flu/glossary/index.htm and the World Health Organization http://www.wpro.who.int/emerging_diseases/glossary_rev_sept28.pdf?ua=1

More information

Rabies virus-like particles expressed in HEK293 cells

Rabies virus-like particles expressed in HEK293 cells Engineering Conferences International ECI Digital Archives Vaccine Technology IV Proceedings Spring 5-21-2012 Rabies virus-like particles expressed in HEK293 cells Diego Fontana Cell Culture Laboratory

More information

Cloning and Expression of Influenza H1N1 NS1 Protein in Escherichia Coli BL21

Cloning and Expression of Influenza H1N1 NS1 Protein in Escherichia Coli BL21 Iran J Biotech. 2014 March; 12(1): e12625. Published online 2014 March 19. DOI: 10.5812/ijb.12625 Research Article Cloning and Expression of Influenza H1N1 NS1 Protein in Escherichia Coli BL21 Marzieh

More information

Cristina Cassetti, Ph.D.

Cristina Cassetti, Ph.D. NIAID Extramural Research Update: Recombinant Influenza Viruses and Biosafety Cristina Cassetti, Ph.D. Influenza Program Officer Division of Microbiology and Infectious Diseases NIAID Influenza virus DMID

More information

Avian Influenza Virus H7N9. Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences

Avian Influenza Virus H7N9. Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences Avian Influenza Virus H7N9 Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences Avian Influenza Virus RNA virus, Orthomyxoviruses Influenza A virus Eight Gene segments

More information

Human Influenza. Dr. Sina Soleimani. Human Viral Vaccine Quality Control 89/2/29. November 2, 2011 HVVQC ١

Human Influenza. Dr. Sina Soleimani. Human Viral Vaccine Quality Control 89/2/29. November 2, 2011 HVVQC ١ Human Influenza Dr. Sina Soleimani Human Viral Vaccine Quality Control 89/2/29 November 2, 2011 HVVQC ١ Presentation outline 1. Introduction 2. Virology 3. Classification 4. Hosts 5. Antigenic Specifications

More information

The development of stable influenza vaccine powder formulations for new needle-free dosage forms Amorij, Jean-Pierre

The development of stable influenza vaccine powder formulations for new needle-free dosage forms Amorij, Jean-Pierre University of Groningen The development of stable influenza vaccine powder formulations for new needle-free dosage forms Amorij, Jean-Pierre IMPORTANT NOTE: You are advised to consult the publisher's version

More information

Point of Care Tests for respiratory viruses: impact on clinical outcomes of patients

Point of Care Tests for respiratory viruses: impact on clinical outcomes of patients Point of Care Tests for respiratory viruses: impact on clinical outcomes of patients Dr Sacha Stelzer-Braid Postdoctoral Scientist Virology Research Laboratory (VRL), UNSW and POWH @DrSachaSB Outline 1.

More information

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance Flu Watch MMWR Week 3: January 14 to January 2, 218 All data are provisional and subject to change as more reports are received. Geographic Spread South Carolina reported widespread activity this week.

More information

Application of Reverse Genetics to Influenza Vaccine Development

Application of Reverse Genetics to Influenza Vaccine Development NIAID Application of Reverse Genetics to Influenza Vaccine Development Kanta Subbarao Laboratory of Infectious Diseases NIAID, NIH Licensed Vaccines for Influenza Principle: Induction of a protective

More information

Broadly protective influenza vaccines for pandemic preparedness. Suresh Mittal Department of Comparative Pathobiology Purdue University

Broadly protective influenza vaccines for pandemic preparedness. Suresh Mittal Department of Comparative Pathobiology Purdue University Broadly protective influenza vaccines for pandemic preparedness Suresh Mittal Department of Comparative Pathobiology Purdue University Influenza A Virus Orthomyxovirus Consist of s/s (-) sense RNA 8 segments

More information

Influenza. By Allison Canestaro-Garcia. Disease Etiology:

Influenza. By Allison Canestaro-Garcia. Disease Etiology: Influenza By Allison Canestaro-Garcia Disease Etiology: The flu is an infectious disease caused by a subset of viruses of the family Orthomyxoviridae. There are 7 different viruses in this family, four

More information

100 years of Influenza Pandemic and the prospects for new influenza vaccines

100 years of Influenza Pandemic and the prospects for new influenza vaccines 100 years of Influenza Pandemic and the prospects for new influenza vaccines Dr John McCauley Director, WHO Collaborating Centre for Reference and Research on influenza The Francis Crick Institute London

More information

Immune Responses against a New HIV-1 p24-gp41/pcaggs-il-12 DNA Vaccine in Balb/c Mice

Immune Responses against a New HIV-1 p24-gp41/pcaggs-il-12 DNA Vaccine in Balb/c Mice ISSN 1735-1383 Iran. J. Immunol. June 2012, 9 (2), 86-97 Fatemeh Roodbari, Farzaneh Sabahi, Mohamad Nabi Sarbolouki, Farzaneh Barkhordari, Ahmad Adeli, Amel Jamedar, Fereidoun Mahboudi Immune Responses

More information

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance Flu Watch MMWR Week 4: January 21 to January 27, 218 All data are provisional and subject to change as more reports are received. Geographic Spread South Carolina reported widespread activity this week.

More information

In the Name of God. Talat Mokhtari-Azad Director of National Influenza Center

In the Name of God. Talat Mokhtari-Azad Director of National Influenza Center In the Name of God Overview of influenza laboratory diagnostic technology: advantages and disadvantages of each test available Talat Mokhtari-Azad Director of National Influenza Center Tehran- Iran 1 1)

More information

Influenza B virus, Monoclonal antibody Influenza vaccine

Influenza B virus, Monoclonal antibody Influenza vaccine Key words: Influenza B virus, Monoclonal antibody Influenza vaccine Fig. 1 Number of hospitalized patients due to Influenza B virus infection * Total number of hospitalized patients due to infectious diseases

More information

CURRICULUM VITAE Position: Date of Birth Place of Birth: Gender Marital Status: Nationality: Address: OFFICE: Education: Training: Language:

CURRICULUM VITAE Position: Date of Birth Place of Birth: Gender Marital Status: Nationality:   Address: OFFICE: Education: Training: Language: CURRICULUM VITAE Ali Nour Nematollahi, MSc. Position: Research co-worker, Mycobacteriology Center, Institute Pasteur of Iran Date of Birth: February 6, 1963 Place of Birth: Tehran Gender: male Marital

More information

in vitro in vivo [hemagglutinating virus of Japan envelope (HVJ-E)] HVJ-E (Scid) HVJ-E HVJ-E

in vitro in vivo [hemagglutinating virus of Japan envelope (HVJ-E)] HVJ-E (Scid) HVJ-E HVJ-E 57 pp.19-282007 1. [hemagglutinating virus of Japan envelope (HVJ-E)] HVJ-E HVJ-E 60% 80% (Scid) In vitro HVJ-E HVJ(live HVJ) HVJ-E live HVJ IL-6 RT-PCR HVJ-E CD4 + T CD8 + T T (CTL) HVJ-E Foxp3 + CD4

More information

Global and Regional Situation of Zoonotic Influenza in Humans, and Pandemic Preparedness

Global and Regional Situation of Zoonotic Influenza in Humans, and Pandemic Preparedness Global and Regional Situation of Zoonotic Influenza in Humans, and Pandemic Preparedness Takato Odagiri Director WHO Collaborating Center on Influenza, Tokyo and Influenza Virus Research Center, National

More information

Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine

Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine International Journal of Infectious Diseases (2008) 12, 83 87 http://intl.elsevierhealth.com/journals/ijid Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with

More information

For the control of avian influenza

For the control of avian influenza OIE Regional Expert Group Meeting for the Control of Avian influenza in Asia Sapporo, 3-5 October 2017 For the control of avian influenza Hiroshi Kida Hokkaido University Research Center for Zoonosis Control

More information

Curriculum Vitea. Date of birth: College (High School) : Pooyandegan College. College (Pre-university) : Emam Sadegh

Curriculum Vitea. Date of birth: College (High School) : Pooyandegan College. College (Pre-university) : Emam Sadegh Pedram Pakzad (DDS) Private Office, North Basij Street, Shahid Nikbakht Boulevard, Mobarakeh, 8481817491 Mobile: +989134090831, Work: +9831 52419636, pakzadpedram@yahoo.com, http://www.ppakzad.com Curriculum

More information

Arash Ghanbarian (M.D.)

Arash Ghanbarian (M.D.) P. O. Box: 17385-137 Research Institute for Endocrine Sciences No. 24, Parvaneh St., Yemen St. Evin Tehran 19857 Iran Phone: +98(21) 2243 2500 or +98(21) 8851 9366 Fax : +98(21) 2240 2463 or +98(21) 2241

More information

Introduction. In the past 15 years, several technological advancements have open new perspectives and applications in the field of vaccinology.

Introduction. In the past 15 years, several technological advancements have open new perspectives and applications in the field of vaccinology. Introduction In the past 15 years, several technological advancements have open new perspectives and applications in the field of vaccinology. - Genomics: fasten antigen discovery for complex pathogens

More information

Weekly Influenza & Respiratory Activity: Statistics Summary

Weekly Influenza & Respiratory Activity: Statistics Summary Weekly Influenza & Respiratory Activity: Statistics Summary 2011-12 updated 7/12/12 Influenza Activity in Minnesota Summary of the 2011-12 Season Since the start of the influenza season, 552 people were

More information

Situation of XMRV and Blood Transfusion. Celso Bianco, MD ISBT Working Party on TTID Lisbon, June 19, 2011

Situation of XMRV and Blood Transfusion. Celso Bianco, MD ISBT Working Party on TTID Lisbon, June 19, 2011 Situation of XMRV and Blood Transfusion Celso Bianco, MD ISBT Working Party on TTID Lisbon, June 19, 2011 Lombardi et al. Science 326, 585 (2009) Conclusions: CFS and XMRV XMRV found in 67% of CFS patients

More information

Chapter 14 Part One Biotechnology and Industry: Microbes at Work

Chapter 14 Part One Biotechnology and Industry: Microbes at Work Chapter 14 Part One Biotechnology and Industry: Microbes at Work Objectives: After reading Chapter 14, you should understand How biotechnology has resulted in numerous pharmaceutical products to help lessen

More information

Weekly Influenza Activity: Statistics Summary

Weekly Influenza Activity: Statistics Summary Weekly Influenza Activity: Statistics Summary 2010-11 updated 9/9/11 Summary of the 2010-11 Influenza Season Since the start of the influenza season, 215 schools reported outbreaks of ILI. Influenza Activity

More information

High-Technology Route To Virus Vaccines READ ONLINE

High-Technology Route To Virus Vaccines READ ONLINE High-Technology Route To Virus Vaccines READ ONLINE If you are searching for a book High-Technology Route to Virus Vaccines in pdf form, in that case you come on to the loyal website. We presented the

More information

Curriculum vitae: Name: Azita Zadeh-Vakili Date of birth: Address: Education Record: Bachelor of Science: Master of Science: PhD:

Curriculum vitae: Name: Azita Zadeh-Vakili Date of birth: Address: Education Record: Bachelor of Science: Master of Science: PhD: Curriculum vitae: Name: Azita Zadeh-Vakili Date of birth: June 28 th, 1965. Address: Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, 24 Aarabi St, Velenjak,Tehran,

More information

Requirements for quality control and registration of influenza vaccines developed using novel biotechnological approaches

Requirements for quality control and registration of influenza vaccines developed using novel biotechnological approaches WHO Integrated Meeting on development and clinical trials of Influenza vaccines Hongkong, January 2013 www.pei.de Requirements for quality control and registration of influenza vaccines developed using

More information

Jamshid Khoubi Curriculum vitae 2016

Jamshid Khoubi Curriculum vitae 2016 Jamshid Khoubi Curriculum vitae 2016 First name: Jamshid Last name: Khoubi Sex: Male Nationality: Iranian Date/place of birth: 1981/ Maragheh, East Azarbayjan, Iran Institutional address: Lecturer at health

More information

EPIDEMIOLOGICAL STUDIES

EPIDEMIOLOGICAL STUDIES EPIDEMIOLOGICAL STUDIES EPIDEMIOLOGIC STUDIES EPIDEMIOLOGIC STUDIES 8 Clinical Trial sites in Brasil (NICHD) Transfusion recipient study (NHLBI) Prospective study in Brasil (Yale) Natural history population

More information

Preventive and therapeutic HIV vaccines. Markus Bickel Infektiologikum Frankfurt

Preventive and therapeutic HIV vaccines. Markus Bickel Infektiologikum Frankfurt Preventive and therapeutic HIV vaccines Markus Bickel Infektiologikum Frankfurt No conflicts to declare Disclosures Background FAQ: by patients and colleagues Publication about promising results, especially

More information

CURRICULUM VITAE EDUCATION

CURRICULUM VITAE EDUCATION CURRICULUM VITAE First name: Fatemeh Last name: Nadali Date of birth: 4 Jan 1961 ADD: Pathology Department School of Medicine Isfahan University of Medical Sciences Isfahan IRAN Tel: +98 311 7922475 Mobile:

More information

24 26 January 2013, Hong Kong SAR, CHINA. TITLE from VIEW and SLIDE MASTER February 27, 2013

24 26 January 2013, Hong Kong SAR, CHINA. TITLE from VIEW and SLIDE MASTER February 27, 2013 The first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses 24 26 January 2013, Hong Kong SAR, CHINA 1 TITLE

More information

RT-PCR. variant 2 variant 2 H120. :

RT-PCR. variant 2 variant 2 H120. : RT- * RT- MWG H120 RT- azad.rahimi@gmail.com : * Cavanagh. (Iran//19/08) Hosseini QX Najafi (Iran/QX/H179/11) g PBS IR1 mass IS/720 QX Hashemzadeh RT- RNase SX1 RT- SX2 Nested- RT- SX3 SX3 Denaturation)

More information

Supplementary Figure 1.

Supplementary Figure 1. Supplementary Figure 1. Female Pro-ins2 -/- mice at 5-6 weeks of age were either inoculated i.p. with a single dose of CVB4 (1x10 5 PFU/mouse) or PBS and treated with αgalcer or control vehicle. On day

More information

Kinetics of Primary and Memory Cytotoxic. T Lymphocyte Responses to Herpes. Simplex Virus 1 Infection: Granzyme B. Mediated CTL Activity

Kinetics of Primary and Memory Cytotoxic. T Lymphocyte Responses to Herpes. Simplex Virus 1 Infection: Granzyme B. Mediated CTL Activity ISSN 1735-1383 Iran. J. Immunol. March 2009, 6 (1), 22-27 Masumeh Gorgian Mohammadi, Taravat Bamdad, Masoud Parsania, Hamid Reza Hashemi, Somayeh Puyanfard Kinetics of Primary and Memory Cytotoxic T Lymphocyte

More information

Modeling the Antigenic Evolution of Influenza Viruses from Sequences

Modeling the Antigenic Evolution of Influenza Viruses from Sequences Modeling the Antigenic Evolution of Influenza Viruses from Sequences Taijiao Jiang Center of Systems Medicine, Chinese Academy of Medical Sciences Suzhou Institute of Systems Medicine October 8-10, 2015.

More information

How does the body defend itself?

How does the body defend itself? Prevention of Infection 2 Immunisation 3 rd BDS B. Martin Major World Causes Of Death COUNTRIES Developing Developed Total x10-6 Population 5400 (80%) 1200 (20%) 6600 CAUSE OF DEATH % % % Infectious diseases

More information

ABOLFAZL NICKFARJAM Page 1 of 6

ABOLFAZL NICKFARJAM Page 1 of 6 ABOLFAZL NICKFARJAM Page 1 of 6 ABOLFAZL NICKFARJAM Department of Medical Physics, Faculty of Medicine, Yazd University of Medical Science (Pardis), Alem Sq., Gomnam Blvd., Yazd, Iran. Email: a.nickfarjam@ssu.ac.ir

More information

Weekly Influenza Surveillance Report. Week 11

Weekly Influenza Surveillance Report. Week 11 Weekly Influenza Surveillance Report Week 11 Report produced: 22/03/2001 Influenza activity in Ireland For the week ending the 18/03/01, week 11, influenza activity has increased. Sentinel general practices

More information

Active and Passive Immunization for Avian Influenza Virus Infections

Active and Passive Immunization for Avian Influenza Virus Infections NIAID Active and Passive Immunization for Avian Influenza Virus Infections Kanta Subbarao, MD, MPH Laboratory of Infectious Diseases NIAID, NIH Immortalizing H5 HA-Specific Memory B Cells Collection of

More information

Disclosures. No support One off-label recommendation

Disclosures. No support One off-label recommendation Seasonal Influenza John B. Murphy, MD Professor of Medicine and Family Medicine Warren Alpert Medical School of Brown University Executive Vice President for Physician Affairs, Lifespan 8/21/14 Disclosures

More information

Antibody Dependent Cellular Cytotxic activity: Past and Future. Guido Ferrari, M.D. Duke University Medical Center

Antibody Dependent Cellular Cytotxic activity: Past and Future. Guido Ferrari, M.D. Duke University Medical Center Antibody Dependent Cellular Cytotxic activity: Past and Future Guido Ferrari, M.D. Duke University Medical Center Mechanism of Antibody Dependent Cellular Cytotoxicity (ADCC) ADCC Effector Cells (NK, monocytes/macrophages,

More information

Original Article Polyclonal Antibody against Recombinant Nucleoprotein of the Influenza A Virus (H1N1); Production and Purification

Original Article Polyclonal Antibody against Recombinant Nucleoprotein of the Influenza A Virus (H1N1); Production and Purification Iranian J Virol 2017;11(2): 36-42 2017, Iranian Society of Virology. All rights reserved. Original Article Polyclonal Antibody against Recombinant Nucleoprotein of the Influenza A Virus (H1N1); Production

More information

Reassortment of influenza A virus genes linked to PB1 polymerase gene

Reassortment of influenza A virus genes linked to PB1 polymerase gene International Congress Series 1263 (2004) 714 718 Reassortment of influenza A virus genes linked to PB1 polymerase gene Jean C. Downie* www.ics-elsevier.com Centre for Infectious Diseases and Microbiology,

More information

2. No.38, Apt. Yas 8, Keshvari Town, Third Abshar Ave., Isfahan, Iran. Phone: Mobile:

2. No.38, Apt. Yas 8, Keshvari Town, Third Abshar Ave., Isfahan, Iran. Phone: Mobile: Curriculum Vitae December 2011 Personal Information First name: Ahmad Surname: Salamian Gender: Male Nationality: Iranian Date of Birth: 07.06.1982 Address: 1. Department of Cell and Molecular Biology,

More information

Supplementary Fig. 1. Delivery of mirnas via Red Fluorescent Protein.

Supplementary Fig. 1. Delivery of mirnas via Red Fluorescent Protein. prfp-vector RFP Exon1 Intron RFP Exon2 prfp-mir-124 mir-93/124 RFP Exon1 Intron RFP Exon2 Untransfected prfp-vector prfp-mir-93 prfp-mir-124 Supplementary Fig. 1. Delivery of mirnas via Red Fluorescent

More information

A Novel Recombinant Virus Reagent Products for Efficient Preparation Of Hepatitis B Animal Models

A Novel Recombinant Virus Reagent Products for Efficient Preparation Of Hepatitis B Animal Models About FivePlus Beijing FivePlus Molecular Medicine Institute was established in 2005. The company has been dedicating itself to continuous innovation of viral vectors. The meaning of FivePlus is based

More information

Weekly Influenza News 2016/17 Season. Communicable Disease Surveillance Unit. Summary of Influenza Activity in Toronto for Week 43

Weekly Influenza News 2016/17 Season. Communicable Disease Surveillance Unit. Summary of Influenza Activity in Toronto for Week 43 + Weekly / Influenza News Week 43 (October 23 to October 29, 2016) Summary of Influenza Activity in Toronto for Week 43 Indicator (Click on the indicator Activity Level * Description name for more details)

More information

Perspective in novel TB vaccine development Mohamed Ridha BARBOUCHE M.D., Ph.D. Department of Immunology Institut Pasteur de Tunis

Perspective in novel TB vaccine development Mohamed Ridha BARBOUCHE M.D., Ph.D. Department of Immunology Institut Pasteur de Tunis Perspective in novel TB vaccine development Mohamed Ridha BARBOUCHE M.D., Ph.D. Department of Immunology Institut Pasteur de Tunis Existing TB Vaccine is not effective for global TB epidemic control BCG

More information

Respiratory Syncytial Virus. Respiratory Syncytial Virus. Parainfluenza virus. Acute Respiratory Infections II. Most Important Respiratory Pathogens

Respiratory Syncytial Virus. Respiratory Syncytial Virus. Parainfluenza virus. Acute Respiratory Infections II. Most Important Respiratory Pathogens Acute Respiratory Infections II Most Important Respiratory Pathogens From microbes.historique.net/images An Introduction to One Health Problem Solving PHC 6006 Gregory C. Gray, MD, MPH, FIDSA Professor,

More information

Influenza as Research Trend among Iranians:

Influenza as Research Trend among Iranians: Influenza as Research Trend among Iranians: 2016-2017 Masoud Mardani MD,MPH,FIDSA,FESCMID, Professor Of Infectious Diseases and Tropical Medicine, Shahid Beheshti University of Medical Sciences, Tehran,

More information

ph1n1 H3N2: A Novel Influenza Virus Reassortment

ph1n1 H3N2: A Novel Influenza Virus Reassortment ph1n1 H3N2: A Novel Influenza Virus Reassortment Jonathan Gubbay Medical Microbiologist Public Health Laboratory Public Health Ontario June 16, 2011 ph1n1 H3N2 Reassortment: Talk Overview Explain strain

More information

Frequency of Herpes simplex Infection in Iranian Children with Aseptic Meningitis: A systematic review and meta-analysis

Frequency of Herpes simplex Infection in Iranian Children with Aseptic Meningitis: A systematic review and meta-analysis International Journal of Current Research in Medical Sciences ISSN: 2454-5716 P-ISJN: A4372-3064, E -ISJN: A4372-3061 www.ijcrims.com Original Research Article Volume 5, Issue 3-2019 DOI: http://dx.doi.org/10.22192/ijcrms.2019.05.03.003

More information

PREVALENCE OF AIV SUBTYPE H9 AMONG POULTRY WITH RESPIRATORY SIGNS IN IRAQ

PREVALENCE OF AIV SUBTYPE H9 AMONG POULTRY WITH RESPIRATORY SIGNS IN IRAQ Bulgarian Journal of Veterinary Medicine, 2016 ONLINE FIRST ISSN 1311-1477; DOI: 10.15547/bjvm.1022 Original article PREVALENCE OF AIV SUBTYPE H9 AMONG POULTRY WITH RESPIRATORY SIGNS IN IRAQ Summary Q.

More information

Bilateral cooperation between a laboratory in Korea and laboratories in other countries:

Bilateral cooperation between a laboratory in Korea and laboratories in other countries: Bilateral cooperation between a laboratory in Korea and laboratories in other countries: the basis for a future extended network Yi Seok Joo DVM, Ph D National Veterinary Research and Quarantine Service

More information

Int. J. Med. Sci :

Int. J. Med. Sci : Int. J. Med. Sci. 2004 1: 193-200 193 Research paper Received: 2004.06.16 Accepted: 2004.09.25 Published:2004.10.15 International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2004 1:193-200

More information

Min Levine, Ph. D. Influenza Division US Centers for Disease Control and Prevention. June 18, 2015 NIBSC

Min Levine, Ph. D. Influenza Division US Centers for Disease Control and Prevention. June 18, 2015 NIBSC Workshop on Immunoassay Standardization for Universal Flu Vaccines Min Levine, Ph. D. Influenza Division US Centers for Disease Control and Prevention June 18, 2015 NIBSC 1 Multiple Immune Mechanisms Contribute

More information

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID 2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: AUSTRIA Lisbon, 12 th October 201 Epidemiological update 2 HIV notifications in PWID Number of HIV cases

More information

Influenza. Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong

Influenza. Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong Influenza Paul K. S. Chan Department of Microbiology The Chinese University of Hong Kong Classification & Nomenclature Influenza virus A, B & C Influenza A : Haemagglutinin (H 1-16), neuraminidase (N1-9)

More information

Pandemic Influenza influenza epidemic: realization of a worst-case scenario

Pandemic Influenza influenza epidemic: realization of a worst-case scenario Pandemic Influenza October 9, 2006 1918 influenza epidemic: realization of a worst-case scenario First case: Albert Mitchell, Camp Funston, KS, March 11, 1918 Up to 20% of all humans infected 20-50 million

More information

D-LAB HEALTH SP 725. Jose Gomez-Marquez

D-LAB HEALTH SP 725. Jose Gomez-Marquez SP 725 Jose Gomez-Marquez 1 Vaccine Preventable Diseases Causes of 2.5 million child deaths out of 10.5 million child deaths globally, 2002 Source: WHO Wkly Epidemiol Rec. (2006) 81:189-196. 2 Rationale

More information

Original Article Identification of Different Serotypes of Infectious Bronchitis Viruses in Allantoic Fluid Samples with Single and Multiplex RT- PCR

Original Article Identification of Different Serotypes of Infectious Bronchitis Viruses in Allantoic Fluid Samples with Single and Multiplex RT- PCR Iranian Journal of Virology 2009;3(2): 24-29 2009, Iranian Society for Virology Original Article Identification of Different Serotypes of Infectious Bronchitis Viruses in Allantoic Fluid Samples with Single

More information

Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma

Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma International Journal of Infectious Diseases (2009) 13, 685 689 http://intl.elsevierhealth.com/journals/ijid Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma Arezoo Aghakhani

More information

CURRICULUM VITAE Shahla Z. Abghari

CURRICULUM VITAE Shahla Z. Abghari Shahla Z. Abghari, Ph. D. Updated March 4, 2014 PAGE 1 CURRICULUM VITAE Shahla Z. Abghari U. S. CITIZENSHIP: April 1992 EDUCATION: 1966-1970 B.S., Biology, Teachers University, Tehran, Iran 1967-1971 B.A.,

More information

What are ADCC antibodies? Work on influenza ADCC antibodies Greenberg et al, Hashimoto et al. First describes Fluspecific

What are ADCC antibodies? Work on influenza ADCC antibodies Greenberg et al, Hashimoto et al. First describes Fluspecific 14/7/214 Acknowledgement antibodies against diverse influenza strains: Implications for universal vaccination Sinth Jegaskanda PhD Prof Stephen Kent University of Melbourne What are antibodies? Work on

More information

The QIAsymphony RGQ as a platform for laboratory developed tests

The QIAsymphony RGQ as a platform for laboratory developed tests The QIAsymphony RGQ as a platform for laboratory developed tests James B. Mahony Ph.D., F.A.A.M., F.C.C.M. Director, Regional Virology Laboratory St. Joseph s Healthcare, Hamilton Assistant Dean Medical

More information

How Vaccines Work. Jerry Sadoff MD Crucell Vaccine Institute

How Vaccines Work. Jerry Sadoff MD Crucell Vaccine Institute How Vaccines Work Jerry Sadoff MD Crucell Vaccine Institute Questions you will be able to answer at the end of this session How do Vaccines Work? How do we develop vaccines? How do we manufacture vaccines?

More information

Will Antigen Depletion Restore HBVspecific

Will Antigen Depletion Restore HBVspecific Will Antigen Depletion Restore HBVspecific Immunity? Adam J. Gehring, Ph.D. Biology Lead Toronto Centre for Liver Disease University Health Network (UHN) Assistant Professor Department of Immunology University

More information

Recombinant Baculovirus Derived HIV-1 Virus-Like Particles Elicit Potent Neutralizing Antibody Responses

Recombinant Baculovirus Derived HIV-1 Virus-Like Particles Elicit Potent Neutralizing Antibody Responses Recombinant Baculovirus Derived HIV-1 Virus-Like Particles Elicit Potent Neutralizing Antibody Responses Weimin Liu University of Alabama at Birmingham Introduction and Rationale Virus-like particles (VLPs)

More information

E E Hepatitis E SARS 29, Lancet. E A B Enterically-Transmitted Non-A, Hepatitis E. Virus HEV nm. 1.35g/cm s ALT AST HEV HEV

E E Hepatitis E SARS 29, Lancet. E A B Enterically-Transmitted Non-A, Hepatitis E. Virus HEV nm. 1.35g/cm s ALT AST HEV HEV 7850 2004 Hepatitis E Tian-Cheng LI Naokazu TAKEDA Tatsuo MIYAMURA SARS 8 Lancet E E E Hepatitis E VirusHEV E E HEV HEV E 1955 29,000 E E A A B Enterically-Transmitted Non-A, Non-B Hepatitis 1983 Balayan

More information

CURRICULUM VITAE. Name: Sepha Nyatichi Mabeya Place of Birth: Nyamira. Marital Status: Married. Education Background

CURRICULUM VITAE. Name: Sepha Nyatichi Mabeya Place of Birth: Nyamira. Marital Status: Married. Education Background CURRICULUM VITAE SEPHA NYATICHI MABEYA Jomo Kenyatta University of Agriculture & Technology School of Biomedical Sciences Department of Medical Microbiology P.O Box 62000 00200 Nairobi Mobile: (254) 0722

More information